Organogenesis Holdings Inc. (ORGO) vs PepGen Inc. (PEPG)
A side-by-side comparison of Organogenesis Holdings Inc. and PepGen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ORGO
Organogenesis Holdings Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
PEPG
PepGen Inc.
$2.31HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — ORGO vs PEPG
growth of $100 · dividends reinvested · last 4yORGO -82.5% (-35.3%/yr)PEPG -81.7% (-34.6%/yr)PEPG compounded faster over this window
ORGO PEPG
ORGO vs PEPG: by the numbers
- •ORGO is the larger company ($170M vs $159M market cap).
- •Both run net losses; PEPG's is the smaller (0.00% vs -19.76% net margin).
Metrics side by side
Valuation
| Metric | ORGO | PEPG |
|---|---|---|
| P/S ratio | 0.37 | N/A |
| P/B ratio | 1.15 | 1.33 |
| EV / EBITDA | 214.03 | N/A |
| FCF yield | 12.27% | N/A |
Profitability
| Metric | ORGO | PEPG |
|---|---|---|
| Gross margin | 67.59% | 0.00% |
| Operating margin | 9.92% | 0.00% |
| Net margin | -19.76% | 0.00% |
| ROE | -31.32% | -60.19% |
| ROIC | -8.34% | -57.59% |
Growth (annualized)
| Metric | ORGO | PEPG |
|---|---|---|
| Revenue CAGR (5Y) | 1.05% | N/A |
| FCF CAGR (5Y) | -5.54% | N/A |
| Total return CAGR (5Y) | -37.41% | N/A |
Go deeper
Dig into the metrics
Organogenesis ROEPepGen ROEOrganogenesis operating marginPepGen operating marginOrganogenesis revenue growthPepGen revenue growthOrganogenesis free cash flowPepGen free cash flow
Organogenesis & PepGen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.